Select Medical (NYSE:SEM) Stock Rating Lowered by Mizuho

Posted by on May 14th, 2026

Select Medical (NYSE:SEM – Get Free Report) was downgraded by stock analysts at Mizuho from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Marketbeat reports. They currently have a $16.50 target price on the health services provider’s stock. Mizuho’s target price would indicate a potential upside of 0.15% from the stock’s previous close.

Several other equities research analysts have also recently issued reports on the stock. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Zacks Research raised shares of Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, February 20th. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $15.50.

Get Our Latest Report on Select Medical

Select Medical Stock Performance

Shares of Select Medical stock opened at $16.48 on Tuesday. The business’s 50 day moving average price is $16.35 and its 200 day moving average price is $15.37. The company has a market cap of $2.04 billion, a price-to-earnings ratio of 15.54, a PEG ratio of 0.94 and a beta of 1.02. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. Select Medical has a one year low of $11.65 and a one year high of $16.99.

Select Medical (NYSE:SEM – Get Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period last year, the business earned $0.44 earnings per share. The firm’s revenue was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, research analysts predict that Select Medical will post 1.27 EPS for the current year.

Select Medical declared that its board has approved a stock repurchase plan on Thursday, February 19th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to buy up to 49.5% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Institutional Investors Weigh In On Select Medical

Hedge funds and other institutional investors have recently made changes to their positions in the business. Quarry LP purchased a new stake in Select Medical during the fourth quarter worth approximately $26,000. Quantbot Technologies LP acquired a new stake in Select Medical during the third quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in Select Medical during the fourth quarter worth approximately $28,000. Hantz Financial Services Inc. lifted its position in shares of Select Medical by 214.7% during the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock worth $38,000 after buying an additional 1,739 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of Select Medical by 37.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after buying an additional 788 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

(Get Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.

Featured Stories

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.